Swedbank AB Cuts Stock Holdings in Walgreens Boots Alliance, Inc. $WBA

Swedbank AB decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 96.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,025 shares of the pharmacy operator’s stock after selling 440,549 shares during the quarter. Swedbank AB’s holdings in Walgreens Boots Alliance were worth $172,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Charles Schwab Investment Management Inc. boosted its stake in Walgreens Boots Alliance by 10.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 14,580,827 shares of the pharmacy operator’s stock worth $162,868,000 after buying an additional 1,425,689 shares in the last quarter. Deutsche Bank AG lifted its stake in Walgreens Boots Alliance by 23.5% in the first quarter. Deutsche Bank AG now owns 7,567,154 shares of the pharmacy operator’s stock worth $84,525,000 after acquiring an additional 1,441,780 shares during the period. Bank of New York Mellon Corp lifted its position in Walgreens Boots Alliance by 3.9% during the first quarter. Bank of New York Mellon Corp now owns 5,645,380 shares of the pharmacy operator’s stock valued at $63,059,000 after buying an additional 212,997 shares during the period. National Bank of Canada FI lifted its position in Walgreens Boots Alliance by 1,223.1% during the first quarter. National Bank of Canada FI now owns 3,582,442 shares of the pharmacy operator’s stock valued at $40,016,000 after buying an additional 3,311,682 shares during the period. Finally, Wealthquest Corp purchased a new stake in shares of Walgreens Boots Alliance in the 1st quarter worth approximately $38,457,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $11.98 on Tuesday. The stock’s fifty day moving average is $11.85 and its 200 day moving average is $11.41. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $13.25. The firm has a market capitalization of $10.37 billion, a PE ratio of -1.64, a PEG ratio of 1.42 and a beta of 0.80. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.32 and a current ratio of 0.60.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.The business had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. During the same quarter last year, the firm posted $0.63 earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. UBS Group reiterated a “neutral” rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Morgan Stanley restated an “underweight” rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, six have given a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Reduce” and an average price target of $10.15.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.